Opioid-related US hospital discharges by type, 1993-2016
- PMID: 31229192
- PMCID: PMC6592613
- DOI: 10.1016/j.jsat.2019.05.003
Opioid-related US hospital discharges by type, 1993-2016
Abstract
Objective: To classify and compare US nationwide opioid-related hospital inpatient discharges over time by discharge type: 1) opioid use disorder (OUD) diagnosis without opioid overdose, detoxification, or rehabilitation services, 2) opioid overdose, 3) OUD diagnosis or opioid overdose with detoxification services, and 4) OUD diagnosis or opioid overdose with rehabilitation services.
Methods: Survey-weighted national analysis of hospital discharges in the Healthcare Cost and Utilization Project National Inpatient Sample yielded age-adjusted annual rates per 100,000 population. Annual percentage change (APC) in the rate of opioid-related discharges by type during 1993-2016 was assessed.
Results: The annual rate of hospital discharges documenting OUD without opioid overdose, detoxification, or rehabilitation services quadrupled during 1993-2016, and at an increased rate (8% annually) during 2003-2016. The discharge rate for all types of opioid overdose increased an average 5-9% annually during 1993-2010; discharges for non-heroin overdoses declined 2010-2016 (3-12% annually) while heroin overdose discharges increased sharply (23% annually). The rate of discharges including detoxification services among OUD and overdose patients declined (-4% annually) during 2008-2016 and rehabilitation services (e.g., counselling, pharmacotherapy) among those discharges decreased (-2% annually) during 1993-2016.
Conclusions: Over the past two decades, the rate of both OUD diagnoses and opioid overdoses increased substantially in US hospitals while rates of inpatient detoxification and rehabilitation services identified by diagnosis codes declined. It is critical that inpatients diagnosed with OUD or treated for opioid overdose are linked effectively to substance use disorder treatment at discharge.
Keywords: Analgesics; Health services research; Opioid; Substance-related disorders.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Financial disclosures
The authors have no relevant financial relationships interest to disclose.
Figures
Similar articles
-
US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.J Subst Abuse Treat. 2018 Sep;92:35-39. doi: 10.1016/j.jsat.2018.06.008. Epub 2018 Jun 20. J Subst Abuse Treat. 2018. PMID: 30032942 Free PMC article.
-
Characteristics of Hospitalized Adults with Opioid Use Disorder in the United States: Nationwide Inpatient Sample.Pain Physician. 2021 Aug;24(5):327-334. Pain Physician. 2021. PMID: 34323434
-
Treatment utilization among persons with opioid use disorder in the United States.Drug Alcohol Depend. 2016 Dec 1;169:117-127. doi: 10.1016/j.drugalcdep.2016.10.015. Epub 2016 Oct 19. Drug Alcohol Depend. 2016. PMID: 27810654 Free PMC article.
-
Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations.J Neurol Sci. 2020 Apr 15;411:116718. doi: 10.1016/j.jns.2020.116718. Epub 2020 Feb 5. J Neurol Sci. 2020. PMID: 32078842 Review.
-
Artificial intelligence interventions focused on opioid use disorders: A review of the gray literature.Am J Drug Alcohol Abuse. 2021 Jan 2;47(1):26-42. doi: 10.1080/00952990.2020.1817466. Epub 2020 Oct 2. Am J Drug Alcohol Abuse. 2021. PMID: 33006905 Review.
Cited by
-
Assessment of Annual Cost of Substance Use Disorder in US Hospitals.JAMA Netw Open. 2021 Mar 1;4(3):e210242. doi: 10.1001/jamanetworkopen.2021.0242. JAMA Netw Open. 2021. PMID: 33666661 Free PMC article.
-
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.Subst Abus. 2020;41(3):269-274. doi: 10.1080/08897077.2020.1787300. Subst Abus. 2020. PMID: 32697171 Free PMC article.
-
Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study.PLoS One. 2022 Dec 15;17(12):e0278208. doi: 10.1371/journal.pone.0278208. eCollection 2022. PLoS One. 2022. PMID: 36520863 Free PMC article.
-
Expanding Inpatient Addiction Consult Services Through Accountable Care Organizations for Medicaid Enrollees: A Modeling Study.J Addict Med. 2022 Sep-Oct 01;16(5):570-576. doi: 10.1097/ADM.0000000000000972. Epub 2022 Feb 8. J Addict Med. 2022. PMID: 35135988 Free PMC article.
-
Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study.Addict Sci Clin Pract. 2023 Jul 11;18(1):42. doi: 10.1186/s13722-023-00396-9. Addict Sci Clin Pract. 2023. PMID: 37434260 Free PMC article.
References
-
- Centers for Disease Control and Prevention. (2017, Jun 26, 2017). Bridged-race population estimates -Data files and documentation Retrieved from https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm
-
- Florida Alcohol & Drug Abuse Association Cost-benefit analyses: Substance abuse treatment is a sound investment. Retrieved from https://www.fadaa.org/.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous